The Global Diagnostic Radiopharmaceuticals & Contrast Media Market research report aims to provide an unbiased and a comprehensive outlook of the Global market to the readers. Analysts have studied the key trends defining the trajectory of the market. The research report also includes an assessment of the achievements made by the players in the Diagnostic Radiopharmaceuticals & Contrast Media Market so far.
Exclusive offer: Up to 30% discount on this report
Buy the Latest Detailed Report @:
Bayer AG, GE Healthcare, Cardinal Health Inc., Nordion Inc., Siemens Healthineers and other for more company coverage please register for sample inquiry.
The global diagnostic radiopharmaceuticals and contrast media market is growing at a steady rate, due to factors, such as technological developments, increasing diagnostic applications in various diseases, government support, and rising cases of chronic diseases. Also, factors, such as shorter half-life of radiopharmaceuticals, stringent regulatory framework, and high capital investment, are expected to hinder the market growth. The development in the minimally invasive therapeutic procedures has encouraged the usage of imaging equipment. This increase in the demand for image guidance has propelled the market. Additionally, medical imaging has witnessed numerous advancements in recent times. The emerging technologies help in enhancing the resolution and quality of the medical images, in turn, propelling the demand for contrast media and diagnostic radiopharmaceuticals. Rising cancer cost is another factor, which is impacting healthcare costs. The government is taking several initiatives for better cancer management. These initiatives are likely to affect the imaging industry, as they give the multinational companies a potential place to make significant investments.
Inquire for sample before purchase:
Scope of the Report
Radiopharmaceuticals are a group of pharmaceutical drugs that have radioactivity and can be used as diagnostics and therapeutic agents. Contrast media is the substance used to enhance the contrast of an image, hence, making an image more detailed and apparent. Contrast media is increasingly being used in various medical imaging techniques, such as MRI and CT. This report analyzes and discusses the global radiopharmaceuticals and contrast media market.
Cardiology Sub-segment Captured the Largest Market Share and is Expected to Retain its Dominance
The major factor driving the growth of the market is the rising prevalence of cardiovascular diseases over the world. According to the estimates of the World Health Organization (WHO), in 2016, 17.9 million people died from CVDs. SPECT, which stands for single photon emission computed tomography, is a non-invasive procedure that can accurately identify areas of abnormal myocardial perfusion. It is also used to determine the functional capacity of the heart muscle and is able to separate living tissue from an irreversibly damaged tissue. This diagnostic procedure helps physicians find out if there are blockages in the coronary (heart) arteries, as well as to determine if the patient should undergo a coronary angiogram. In SPECT, cardiac-specific radiopharmaceuticals, such as 99mTc-tetrofosmin (Myoview, GE healthcare), 99mTc-sestamibi (Cardiolite, Bristol-Myers Squibb), or Thallium-201 chloride are administered. Hence, factors, such as the rising prevalence of cardiovascular diseases and technological advancements in the field of diagnostics, are expected to drive the growth of the market over the forecast period.
Get Discount on this Report:
Influence of the Diagnostic Radiopharmaceuticals & Contrast Media market report:
- Comprehensive assessment of all opportunities and risk in the Diagnostic Radiopharmaceuticals & Contrast Media market.
- Diagnostic Radiopharmaceuticals & Contrast Media market recent innovations and major events.
- Detailed study of business strategies for growth of the Diagnostic Radiopharmaceuticals & Contrast Media market-leading players.
- Conclusive study about the growth plot of Diagnostic Radiopharmaceuticals & Contrast Media market for forthcoming years.
- In-depth understanding of Diagnostic Radiopharmaceuticals & Contrast Media market-particular drivers, constraints and major micro markets.
- Favorable impression inside vital technological and market latest trends striking the Diagnostic Radiopharmaceuticals & Contrast Media market.
We Offer Customization On Report Based On Specific Client Requirement:
– Free country Level analysis for any 5 countries of your choice.
– Free Competitive analysis of any 5 key market players.
– Free 40 analyst hours to cover any other data point.
Irfan Tamboli (Sales)
Phone: + 1704 266 3234 | +91-750-707-8687
email@example.com | firstname.lastname@example.org